Literature DB >> 7870953

Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats.

D C Roberts1.   

Abstract

Intravenous self-administration of GBR 12909, an indirect dopamine agonist, was examined on a Fixed Ratio (FR 1) and a Progressive Ratio (PR) schedule of reinforcement in rats. Subjects were first trained to self-administer cocaine (1.5 mg/kg/inj) during daily 5 h sessions, after which GBR 12909 (0.187-1.5 mg/kg/inj) was substituted. On the FR 1 schedule, the inter-infusion interval for GBR 12909 self-administration was directly related to dose and was approximately three times longer than that established for equivalent doses of cocaine. Breaking points on the PR schedule were comparable for GBR 12909 and cocaine self-administration. The data indicate that, compared to cocaine, GBR 12909 has a longer duration of action and a similar reinforcing efficacy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870953     DOI: 10.1007/bf02245524

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Progressive ratio and fixed ratio schedules of cocaine-maintained responding in baboons.

Authors:  R R Griffiths; L D Bradford; J V Brady
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

2.  Comparison of progressive-ratio performance maintained by cocaine, methylphenidate and secobarbital.

Authors:  R R Griffiths; J D Findley; J V Brady; K Dolan-Gutcher; W W Robinson
Journal:  Psychopharmacologia       Date:  1975-07-23

3.  GBR 12909 reverses the SCH 23390 inhibition of rewarding effects of brain stimulation.

Authors:  P P Rompré; P Bauco
Journal:  Eur J Pharmacol       Date:  1990-06-21       Impact factor: 4.432

4.  Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment.

Authors:  D C Roberts; E A Loh; G Vickers
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Progressive-ratio performance maintained by drug infusions: comparison of cocaine, diethylpropion, chlorphentermine, and fenfluramine.

Authors:  R R Griffiths; J V Brady; J D Snell
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

6.  Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey.

Authors:  L L Howell; L D Byrd
Journal:  J Pharmacol Exp Ther       Date:  1991-07-01       Impact factor: 4.030

7.  Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat.

Authors:  A E Kelley; C G Lang
Journal:  Eur J Pharmacol       Date:  1989-08-29       Impact factor: 4.432

8.  Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward.

Authors:  R A Yokel; R A Wise
Journal:  Science       Date:  1975-02-14       Impact factor: 47.728

9.  Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration.

Authors:  W H Lyness; N M Friedle; K E Moore
Journal:  Pharmacol Biochem Behav       Date:  1979-11       Impact factor: 3.533

10.  Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake.

Authors:  R E Heikkila; L Manzino
Journal:  Eur J Pharmacol       Date:  1984-08-17       Impact factor: 4.432

View more
  21 in total

1.  Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion.

Authors:  Jermaine D Jones; F Scott Hall; George R Uhl; Kenner Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2009-04-17       Impact factor: 3.533

2.  A within-subject assessment of the discriminative stimulus and reinforcing effects of self-administered cocaine in rhesus monkeys.

Authors:  Jennifer L Martelle; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

3.  Parametric analysis of cocaine self-administration under a progressive-ratio schedule in rhesus monkeys.

Authors:  J K Rowlett; B W Massey; M S Kleven; W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

4.  Blockade of hypocretin receptor-1 preferentially prevents cocaine seeking: comparison with natural reward seeking.

Authors:  Rémi Martin-Fardon; Friedbert Weiss
Journal:  Neuroreport       Date:  2014-05-07       Impact factor: 1.837

5.  Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system.

Authors:  S R Tella; B Ladenheim; A M Andrews; S R Goldberg; J L Cadet
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

6.  Effects of drug history on the acquisition of responding maintained by GBR 12909 in rhesus monkeys.

Authors:  F H Wojnicki; J R Glowa
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

7.  In vivo reduction of striatal D1R by RNA interference alters expression of D1R signaling-related proteins and enhances methamphetamine addiction in male rats.

Authors:  Alison D Kreisler; Michael J Terranova; Sucharita S Somkuwar; Dvijen C Purohit; Shanshan Wang; Brian P Head; Chitra D Mandyam
Journal:  Brain Struct Funct       Date:  2020-04-03       Impact factor: 3.270

Review 8.  Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction.

Authors:  Richard B Rothman; Michael H Baumann; Thomas E Prisinzano; Amy Hauck Newman
Journal:  Biochem Pharmacol       Date:  2007-08-09       Impact factor: 5.858

9.  Comparison of the reinforcing efficacy of cocaine and procaine in rhesus monkeys responding under a progressive-ratio schedule.

Authors:  W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

10.  Short-acting cocaine and long-acting GBR-12909 both elicit rapid dopamine uptake inhibition following intravenous delivery.

Authors:  R A España; D C S Roberts; S R Jones
Journal:  Neuroscience       Date:  2008-07-01       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.